Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Mar 10;66(6):753–764. doi: 10.1007/s00262-017-1977-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2017

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

Fig. 3 — Comparisons of levels of different subsets of circulating myeloid cells between PBC patients with different tumor stages and histological grades. Scatter plots showing calculated percentages ± SEM of CD33⁺CD11b⁺HLA-DR^−/lowCD14⁺ M-MDSC, CD33⁺CD11b⁺HLA-DR^−/lowCD15⁺ N/G-MDSC and CD33⁺CD11b⁺HLA-DR^−/lowCD14⁻CD15⁻ IM-MDSC in patients with stage I (n = 9) compared to stage II and III patients (n = 14) (a) and calculated percentages ± SEM of CD33⁺CD11b⁺HLA-DR⁺ APC (b). Scatter plots showing calculated percentages ± SEM of M-MDSC, N/G-MDSC and IM-MDSC in patients with histological grade I and II (n = 11) compared to grade III patients (n = 12) (c) and calculated percentages ± SEM of APC (d)